Fenretinide and risk reduction of second breast cancer

Nat Clin Pract Oncol. 2007 Feb;4(2):64-5. doi: 10.1038/ncponc0735.
No abstract available

Publication types

  • Clinical Trial, Phase III
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Anticarcinogenic Agents / therapeutic use*
  • Breast Neoplasms / prevention & control*
  • Breast Neoplasms / surgery
  • Carcinoma, Intraductal, Noninfiltrating / prevention & control*
  • Carcinoma, Intraductal, Noninfiltrating / surgery
  • Female
  • Fenretinide / therapeutic use*
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Neoplasms, Second Primary / prevention & control*
  • Treatment Outcome

Substances

  • Anticarcinogenic Agents
  • Fenretinide